The PurpleLab^® Resource Center

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

The US spends twice as much on health per person as other high-income nations. Health expenditures per person reached $13,432 in 2023, which was over $3,700 more than any other peer nation.  According to the Commonwealth Fund, “reductions in administrative burdens and drug costs could substantially reduce the difference between U.S. and peer nation health…

This study was run to understand variations in treatment with resulting shifts in care management that aligns with patient preferences and migraine-specific care and observe if a relationship exists between racially diverse patients seeking care and healthcare provider (HCP) specialties, including alternative medicine providers. Diane Faraone, PharmD, Karina D’Angelo PhD., Andreas Lysandropoulos, MD, PhD. Background…

Winning the Long Game: Life Science Companies Must Focus on Market Access – Not Just Clinical Trials Life Science Clinical trials are just the start. Discover how real-world data help life sciences companies implement market access strategies designed to get new drugs to patients who need them. It takes life sciences companies a long time…